ENTOS
Live / Applied — Third extension granted (statement of use) (as of 30 Dec 2025)
What this means for you
Not registered yet, but its 14 Sept 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97590573
- Mark type
- Stylized text
- Filed
- 14 Sept 2022
- Published for opposition
- 07 May 2024
- Attorney of record
- Theodore R. Remaklus
Goods and services
- Class 001 — Chemicals: Reagents for scientific purposes for use in nucleic acid isolation and purification; cell culture media for laboratory use for use in the biotechnological industry; diagnostic reagents for clinical laboratory use; diagnostic preparations for clinical laboratory use
- Class 005 — Pharmaceuticals: Pharmaceutical and medicinal preparations and substances, namely, therapeutic proteins and antibodies for the treatment of infectious diseases, namely, viral infections, bacterial infections, fungal infections, parasitic infections and prion diseases, infections of multiple organ systems, namely, the lung in the name of pneumonia, kidneys in the name of pyelonephritis, gastrointestinal track in the nature of gastritis, enteritis, colitis, systemic blood infections in the nature of sepsis/septic shock, skin infections in the nature of cellulitis, central nervous system in the nature of meningitis, encephalitis, walled off infections in the nature of abscesses, liver in the nature of hepatitis, head and neck infections in the nature of conjunctivitis, uveitis, sinusitis; chronic diseases, namely, chronic respiratory, pulmonary and lung diseases, chronic inflammatory diseases, chronic cardiovascular diseases, chronic liver diseases, chronic kidney diseases, chronic bone diseases, chronic oral diseases, chronic blood diseases, chronic spleen diseases, chronic pancreatic diseases, chronic thyroid diseases, chronic reproductive disease, chronic gastrointestinal diseases, chronic skin diseases, chronic bone diseases; vaccines that are viral, bacterial, fungal for veterinary use; therapeutic and preventative cancer vaccines for veterinary use; diagnostic preparations for medical purposes for detecting genetic predispositions; pharmaceutical preparations for the diagnosis, treatment and prevention of a variety of diseases and disorders, namely, cancer, inflammatory diseases and disorders, namely, inflammatory bowel diseases and disorders, inflammatory connective tissue diseases and disorders, inflammatory pelvic diseases and disorders, asthma, coeliac disease, hepatitis which is viral, alcoholic, autoimmune, inflammatory bowel disease, namely, Crohn's and ulcerative colitis, fatty liver disease, endometriosis, arthritis, autoimmune diseases and disorders, hypoglycemia, gout, osteoarthritis, anemia, infectious diseases, namely, blood infections, respiratory infections, topical infections, cardiovascular diseases and disorders, neurological diseases and disorders, namely, cerebral palsy, brain injury, spinal cord injury and seizure disorders, hematological diseases and disorders, dermatological diseases and disorders, namely, dermatitis, skin pigmentation diseases, psoriasis, eczema, acne, shingles, hives, rosacea, ophthalmological diseases and disorders, gastrointestinal diseases and disorders, genitourinary diseases and disorders, namely, urological diseases and disorders, infertility, sexually transmitted diseases, acute renal failure, benign ptostatic hyperplasia, endometrial ablation, renal diseases and disorders, connective tissues diseases and disorders, and enzyme deficiency diseases and disorders, rare and orphan diseases, and rare genetic diseases and disorders, namely, rare neurological and nervous system diseases and other mental illnesses, rare inflammatory diseases, rare cardiovascular diseases, rare kidney diseases, rare bone diseases, rare oral diseases, rare blood diseases, rare spleen diseases, rare pancreatic diseases, rare thyroid diseases, rare reproductive disease, rare gastrointestinal diseases, rare skin diseases, rare bone diseases; cell culture media for cultivating human, animal, plant or microorganism cells for use in the biotechnological industry
- Class 009 — Scientific and electric apparatus: Nucleic acid sequencers for scientific purposes
- Class 010 — Medical apparatus: Medical devices for the qualitative detection and testing of DNA and RNA in human specimens for the detection of influenza viruses and nucleic acid detection
Owner
- Entos Pharmaceuticals Inc., Edmonton, Alberta, CA
- Entos Pharmaceuticals Inc., Edmonton, Alberta, CA
Prosecution history
- 30 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Dec 2025 — SOU EXTENSION 3 GRANTED
- 28 Dec 2025 — SOU EXTENSION 3 FILED
- 29 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Sept 2025 — CORRECTED NOA E-MAILED
- 05 Sept 2025 — SOU EXTENSION 2 GRANTED
- 29 Jun 2025 — SOU EXTENSION 2 FILED
- 05 Sept 2025 — DIVISIONAL PROCESSING COMPLETE
- 30 Jun 2025 — DIVISIONAL REQUEST RECEIVED
- 30 Jun 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 30 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 07 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Mar 2025 — SOU EXTENSION 1 GRANTED
- 30 Dec 2024 — SOU EXTENSION 1 FILED